Neoplasms, Endometrial Recruiting Phase 3 Trials for Pembrolizumab (DB09037)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03884101Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)Treatment
NCT03517449Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])Treatment